Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ReposiTrak filings document a Nevada operating company that provides SaaS-based traceability, compliance, risk management, and supply chain applications for retailers, wholesalers, suppliers, and food manufacturers. Its Form 8-K disclosures record quarterly results and earnings-call materials, cash dividend declarations, share repurchase authorizations, and material commercial or financing agreements involving its subsidiary PC Group.
Governance filings cover director appointments, committee assignments, annual meeting voting results, executive compensation advisory votes, and common-stock matters. The disclosures also describe the company's product families, public-company governance framework, capital allocation actions, and regulatory context for food safety and supply chain compliance.
ReposiTrak, Inc. director and CEO Randall K. Fields reported an indirect open-market sale of 4,000 shares of Common Stock at a weighted average price of $8.0599 per share. The shares were sold by RK Fields Charitable 2022, LLC under a pre-arranged Rule 10b5-1 trading plan established to help meet charitable commitments, with individual trade prices ranging from $7.91 to $8.17. Following the sale, that LLC holds 85,000 shares, while Fields also reports 3,483,955 shares held directly and additional indirect positions through affiliated entities and his spouse.
ReposiTrak, Inc. director and chief executive officer Randall K. Fields reported that RK Fields Charitable 2022, LLC, an entity he manages as trustee of a charitable remainder unitrust, sold 3,500 shares of common stock on March 9, 2026 at a weighted average price of $8.5612 per share.
The sale was executed automatically under a pre-established Rule 10b5-1 trading plan designed to help meet charitable commitments. After this transaction, that LLC held 89,000 shares, while Fields also reported 3,483,955 shares held directly and additional indirect holdings through Riverview Financial Corp., his spouse, and Fields Management, Inc.
ReposiTrak, Inc. reported that an entity associated with Chief Executive Officer Randall K. Fields sold a total of 7,500 shares of common stock in open‑market transactions. The sales, made by RK Fields Charitable 2022, LLC under a Rule 10b5‑1 trading plan, occurred on March 2, 3, and 4, 2026 at weighted average prices of $8.75, $8.55, and $8.6182 per share, respectively.
The trading plan was adopted by Mr. Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust to help meet charitable commitments. After these sales, RK Fields Charitable 2022, LLC held 92,500 shares of common stock. The filing also lists additional direct and indirect holdings, including 3,483,955 common shares held directly as of March 2, 2026, along with stakes held through Riverview Financial Corp., Fields Management, Inc., and by his spouse, plus holdings of Series B Preferred Stock through Riverview Financial Corp. and his spouse.
ReposiTrak, Inc. director and chief executive officer Randall K. Fields reported indirect sales of company common stock through an affiliated charitable entity. RK Fields Charitable 2022, LLC sold 7,500 shares in open-market transactions, consisting of 5,300 shares on February 25, 2026 at a weighted average price of $8.3369 per share and 2,200 shares on February 24, 2026 at a weighted average price of $8.5026 per share. According to the disclosure, these sales occurred automatically under a pre-established Rule 10b5‑1 trading plan adopted by Fields in his capacity as trustee of a charitable remainder unitrust to help meet charitable commitments, and RK Fields Charitable 2022, LLC held 100,000 shares of ReposiTrak common stock after the transactions.
ReposiTrak, Inc. director and chief executive officer Randall K. Fields reported indirect open-market sales of the company’s common stock by an affiliated charitable entity. On February 19, 2026, RK Fields Charitable 2022, LLC sold 4,500 shares at a weighted average price of $9.0652 per share. On February 20, 2026, the same entity sold 3,000 shares at a weighted average price of $8.8238 per share under a Rule 10b5-1 trading plan adopted to help meet charitable commitments. Following these transactions, this LLC held 107,500 shares, while Fields also reported 3,483,955 shares of common stock held directly and additional indirect holdings through other related entities and his spouse, as well as indirect holdings of Series B preferred stock.
ReposiTrak, Inc. reported solid results for its fiscal second quarter ended December 31, 2025, with revenue rising 7% to $5.9 million and operating income up 34% to $1.8 million, reflecting stronger profitability. GAAP net income to common shareholders increased 13% to $1.6 million, or $0.09 per basic and diluted share, compared with $0.08 a year earlier.
The company ended the quarter with $28.7 million in cash and no bank debt, while year-to-date operating cash flow reached $3.8 million. ReposiTrak continued returning capital by paying a quarterly dividend of $0.02 per share, repurchasing about 79,927 common shares for $1.1 million, and redeeming 70,093 preferred shares for roughly $750,000.
Management highlighted growing adoption of its ReposiTrak Traceability Network and new “Touchless Traceability” technology, supported by recent patent filings. They emphasized a largely recurring SaaS revenue base, rising margins, and a strategy focused on cross-selling, continued investment in traceability solutions, and steady capital returns to shareholders.
ReposiTrak, Inc. reported higher sales and profits for the quarter and six months ended December 31, 2025 while maintaining a strong cash position and returning capital to shareholders.
Quarterly revenue rose to $5.86 million from $5.49 million, driven mainly by recurring subscription and support services across compliance, supply chain and traceability. Net income applicable to common shareholders increased to $1.64 million, with diluted earnings per share of $0.09, up from $0.08 a year earlier, helped by lower cost of services and reduced depreciation and amortization.
For the first half of fiscal 2026, revenue reached $11.83 million and net income applicable to common shareholders was $3.40 million, both above the prior-year period. The company ended the quarter with $28.7 million in cash and cash equivalents and no bank debt, and generated $3.78 million in operating cash flow over six months.
ReposiTrak continued redeeming its Series B preferred stock and repurchased common shares under its long-running buyback program, while also paying cash dividends. A quarterly dividend of $0.02 per share was declared in December 2025. Management highlights growing demand for its traceability platform as the food industry prepares for U.S. FDA FSMA 204 traceability requirements, with the compliance deadline now extended to July 20, 2028.
ReposiTrak, Inc. insider trading disclosure: Randall K. Fields, the company’s Chief Executive Officer, director, and 10% owner, reported automatic sales of ReposiTrak common stock executed by RK Fields Charitable 2022, LLC under a prearranged Rule 10b5-1 trading plan.
The charitable LLC sold 3,000 shares on February 2, 2026 at a weighted average price of $10.4754 per share and 4,500 shares on February 4, 2026 at a weighted average price of $10.6195 per share. Following these transactions, the LLC held 119,500 and then 115,000 shares, respectively, while Fields also reported substantial additional direct and indirect beneficial ownership in common and Series B preferred stock.
ReposiTrak, Inc. insider activity shows stock sales by an entity affiliated with CEO, director and 10% owner Randall K. Fields. RK Fields Charitable 2022, LLC sold 2,500 common shares on February 2, 2026 at a weighted average price of $11.0061 and 5,000 shares on February 4, 2026 at a weighted average price of $10.4697. These automatic sales were made under a pre-arranged Rule 10b5-1 trading plan established to help meet charitable commitments. After these transactions, the LLC still held 122,500 shares, while Fields also reported direct ownership of 3,483,955 common shares and additional indirect holdings through Riverview Financial Corp., his spouse, Fields Management, Inc., and Series B preferred stock interests.
ReposiTrak, Inc. received an updated ownership disclosure from Handelsbanken Fonder, a Swedish mutual fund manager, on an amended Schedule 13G. As of December 31, 2025, Handelsbanken Fonder reported beneficial ownership of 1,177,900 shares of ReposiTrak common stock, representing 6.4% of the class.
The firm reports sole voting and dispositive power over all of these shares and no shared power with others. It certifies that the shares were acquired and are held in the ordinary course of business as a mutual fund complex, and not for the purpose of influencing control of ReposiTrak.